April 13, 2020

黑料网 Updates 黑料网 Appropriateness Criteria

黑料网 releases four new topics and 12 revised topics to support referring physicians and other providers in making the most appropriate imaging or treatment decisions

The 黑料网® (黑料网®) today released an update to its 黑料网 Appropriateness Criteria®, which includes 193 diagnostic imaging and interventional radiology topics with 942 clinical variants covering more than 1,680 clinical scenarios. This update includes four new and 12 revised topics. All topics include a narrative, evidence table and a literature search summary. – written with patients, for patients – are also available for a number of topics.

“Our goal for the appropriate use criteria is to create consistent behaviors for medical imaging and interventional radiology procedures for all patients,” said Frank J. Rybicki, MD, PhD, F黑料网, chair of the 黑料网 Committee on Appropriateness Criteria. “The 黑料网 Appropriateness Criteria continues to be a comprehensive and critical resource that helps providers fulfill the new Protecting Access to Medicare Act requirements while ensuring the highest-quality care.”

The new topics in today’s release are:

Revised topics include:

The 黑料网 Appropriateness Criteria was first introduced in 1993 by expert panels in diagnostic imaging and interventional radiology to help providers make the most appropriate imaging or treatment decision for specific clinical conditions. These guidelines are reviewed annually to help enhance quality of care and contribute to the most efficacious use of radiology.

Referring physicians and other providers may use the 黑料网 Appropriateness Criteria to fulfill new PAMA requirements that they consult appropriate use criteria prior to ordering advanced diagnostic imaging for Medicare patients. The 黑料网 is designated by the Centers for Medicare and Medicaid Services as a qualified Provider-Led Entity.

For more information about 黑料网 Appropriateness Criteria, visit the 黑料网 website.

To arrange an interview with an 黑料网 member, contact Meghan Swope at 703-390-9822 or PR@acr.org.